The purpose of this study is to better define the potential molecular and anti-inflammatory changes induced by the modified Atkins diet in the brains of patients with treatment resistant epilepsy. The investigators plan to enroll 30 subjects overall in this study to compare serologic and brain tissue specimens. At NYU, investigators plan to enroll 20 subjects; an estimated ten (10) subjects will consume a modified Atkins diet for 3-4 weeks prior to surgery and an estimated ten (10) subjects will consume a non-modified, higher carbohydrate diet. Investigators at Saint Barnabas Medical Center plan to enroll 10 subjects in this study to compare serologic and brain tissue specimens. Approximately five (5) subjects will consume a modified Atkins diet for 3-4 weeks prior to surgery and five (5) subjects will consume a non-modified, higher carbohydrate diet. Blood and brain tissue specimens will be obtained at the time of surgery and will be compared. The goal of this study is to identify whether or not there are changes in neuroinflammation or neuroexcitability in the human brain induced by the modified Atkins diet.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
19
For those in the MAD intervention group, the dietitian trains the patient and family in the preparation and management of this specialized therapy including sick-day guidelines, meal planning, carbohydrate counting and trouble-shooting. Written and verbal education including, but not limited to: recipes, education materials, sample meal plans and carbohydrate counters are provided to the patient during the initial education session. The caregiver/patient is trained in the outpatient setting and the diet is implemented at home with as much email/phone support from the dietician and ketogenic team as the patient needs to successfully maintain the diet. Medications are all changed over to the lowest carbohydrate forms to eliminate excess carbohydrate intake and all patients are started on vitamin supplements to maintain adequate nutrition.
Institute of Neurology and Neurosurgery at Saint Barnabas
Livingston, New Jersey, United States
NYU Langone Epilepsy Center
New York, New York, United States
Neuroinflammation markers in blood
As measured by level of cytokines IL-6, TNF alpha, and C-reactive protein in blood samples
Time frame: At time of surgery (approximately 3-4 weeks after randomization)
Metabolism
As measured by level of fasting lipid profile, acylcarnitine profile, and beta-hydroxybutyrate in blood
Time frame: At time of surgery (approximately 3-4 weeks after randomization)
Neuroinflammation markers in brain tissue
As measured by level of cytokines, IL6, TNF alpha, and microglial activation and proliferation in brain tissue obtained during durgery
Time frame: At time of surgery (approximately 3-4 weeks after randomization)
Levels of leptin in brain tissue
Time frame: At time of surgery (approximately 3-4 weeks after randomization)
Levels of adenosine in brain tissue
Time frame: At time of surgery (approximately 3-4 weeks after randomization)
Levels of adenosine kinase in brain tissue
Time frame: At time of surgery (approximately 3-4 weeks after randomization)
Levels of adenosite-1 (A1) receptors in brain tissue
Time frame: At time of surgery (approximately 3-4 weeks after randomization)
Levels of enzymes that synthesize glutamate and GABA
As measured in brain tissue obtained during surgery
Time frame: At time of surgery (approximately 3-4 weeks after randomization)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.